DIMENSIONAL FUND ADVISORS LP
Position in ZNTL — Zentalis Pharmaceuticals, Inc.
CIK 354204
AUSTIN, TX
Position in ZNTL
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$636,558
+$506,604 QoQ
Shares Held
272,034
+182.6% QoQ
Ownership
0.382%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 70%
Shared 16%
None 14%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. ZNTL ranks #163 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in ZNTL
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $636,558 | 272,034 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $129,954 | 96,263 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $279,396 | 185,032 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $389,719 | 335,966 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $711,365 | 447,400 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,530,166 | 505,006 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,860,768 | 505,644 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,563,050 | 626,663 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $11,404,816 | 723,656 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $10,969,099 | 724,033 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $9,715,437 | 484,319 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $10,547,830 | 373,904 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,552,105 | 322,797 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,679,242 | 133,031 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $743,974 | 34,348 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,015,049 | 71,710 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,221,902 | 91,502 | Shares | Defined | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||